SEPHIENCE

Approval Id: e0fdc02abf322ed2
Drug Approval Canada Name: SEPHIENCE
Product Name: SEPHIENCE
Status: Marketed
Status Date: 2025-12-01
Original Market Date: 2025-12-01
Drug Class: Human
Dosage Form: Powder
Route Of Administration: Oral
Schedule: PRESCRIPTION
Ahfs: 44:08.00
Atc Original: A16AX28 SEPIAPTERIN
Aig Number: 0167513001
Company Name: PTC THERAPEUTICS INTERNATIONAL LIMITED
Company Address: Unit 1, 52-55 Sir John Rogerson'S Quay, Dublin 2 Dublin Ireland D02 NA07
Company Detail Path: /organization/ptc-therapeutics-international-limited

Agency

Health Canada

Country

🇨🇦

Approval Date

Apr 6, 2026

Approval ID

e0fdc02abf322ed2

Type

Standard